Article Details
Retrieved on: 2022-05-20 14:06:17
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
By Michael Dabaie Immix Biopharma Inc. shares rose 49% to $2.43 after it said IMX-110 showed improved survival over a U.S. Food and Drug...
Article found on: www.marketwatch.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here